Glenmark Life Sciences files RHP; could raise Rs 1,600 cr via IPO | Editorji
editorji
/Assets/images/logo/Punchline_v2.png
download editorji appgoogle apple
  1. home
  2. > Business
  3. > Glenmark Life Sciences files RHP; could raise Rs 1,600 cr via IPO
prev icon/Assets/images/svg/play_white.svgnext button of playermute button of playermaximize icon
mute icontap to unmute
video play icon
00:00/00:00
prev iconplay paus iconnext iconmute iconmaximize icon
close_white icon

Glenmark Life Sciences files RHP; could raise Rs 1,600 cr via IPO

Jul 21, 2021 08:40 IST | By Editorji News Desk

Glenmark Life Sciences has filed its RHP and will be the fifth initial public offering (IPO) to open in July 2021. Here are some details:

Issue date: July 27 to 29

Price band: Rs 695 to Rs 720

Issue size: Rs 1,600 crore

Listing date: August 6

ALSO WATCH: Policybazaar IPO aims to raise Rs 6,500 crore likely to file DRHP in a week

Glenmark Life Sciences is a leading developer and manufacturer of select high-value Active Pharmaceutical Ingredients (APIs) in chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes. The company develops, manufactures, and supplies high-quality APIs globally.

Glenmark Life Sciences files RHP; could raise Rs 1,600 cr via IPO

1/3

Glenmark Life Sciences files RHP; could raise Rs 1,600 cr via IPO

China's big hit for edtech, Investors worried as new ban comes into play wiping out billions

2/3

China's big hit for edtech, Investors worried as new ban comes into play wiping out billions

Ready to open a Tesla factory in India but first reduce import tax; Musk tweets

3/3

Ready to open a Tesla factory in India but first reduce import tax; Musk tweets

Business